Understanding The Amazing Benefits Of Organoids

Organoids are among the advanced model systems the FDA has identified as a means to reduce reliance on animal testing in preclinical research, but their potential extends far beyond this important role.

In this discussion, Dr. Alexis Santana explores Samsung Biologics’ organoid services, explaining what organoids are, how they are developed and applied, and why they are becoming a transformative tool in modern drug development. She highlights how organoid-based models can more accurately replicate human biology, enabling earlier and more predictive insights into efficacy, safety, and toxicity.

By improving translational relevance and streamlining decision-making, these technologies can significantly shorten the timeline from discovery through commercialization while reducing development risk and cost. Looking ahead, Dr. Santana also examines how organoids are poised to reshape the future of drug development by supporting more human-relevant, efficient, and sustainable R&D strategies.